The global amyotrophic lateral sclerosis market is on an upward trajectory, demonstrating significant potential for growth and innovation. According to the latest insights from Future Market Insights ...

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder that is marked by fasciculation, spasticity and progressive weakness of muscles, and results in difficulty speaking ...

It is in late-stage clinical development for the treatment of neurodegenerative diseases such as ALS (amyotrophic lateral sclerosis), progressive MS (multiple sclerosis), and DCM (degenerative ...

Scientists say an extract of the ancient medicinal plant a shwagandha has shown promise as a potential treatment to slow the symptoms of amyotrophic lateral sclerosis, also known as motor neurone ...

"We are now trying also to extend our investigation, to investigate the role of viral infection in other neurodegenerative diseases, like Alzheimer's or amyotrophic lateral sclerosis," also known ...

Amyotrophic lateral sclerosis, commonly known as ALS or Lou Gehrig’s disease, is a degenerative neurological disorder that affects the nerve cells in the brain and spinal cord. Over time ...

And every 90 minutes, another life is lost to this devastating disease. ALS, or amyotrophic lateral sclerosis, is a fatal neurodegenerative disease that gradually robs individuals of their ability ...

Drugmaker Merck said Tuesday it is investing $1 billion in a new Delaware plant to expand domestic production as it prepares to deal with President Trump’s tariffs. The new facility will produce ...

Steve McMichael, the Pro Football Hall of Famer and member of the Chicago Bears' Super Bowl 20 team, has died. He was 67 years old. "The NFL is heartbroken to hear of the passing of Super Bowl ...

Merck & Co. said it expects to lose $200 million to already-announced tariffs in 2025 amid a roiling trade war between the US and China. The estimate doesn’t account for the possibility that ...

Halozyme is not holding back against Merck & Co. in the companies' injectable Keytruda patent dispute, having now escalated a verbal warning into a lawsuit. In a lawsuit filed Thursday in a New ...